Director, Rwe, Cmh

Eli Lilly Eli Lilly · Pharma · ON

The Director, RWE, CMH role at Eli Lilly is responsible for developing and executing the Real-World Evidence strategy within Medical Affairs. This involves designing and overseeing observational studies, registries, and other real-world data analyses to inform clinical practice, regulatory decisions, and healthcare policy. The role requires collaboration with various internal and external stakeholders, including HEOR, Market Access, Regulatory, and KOLs, to generate and disseminate high-quality evidence across the product lifecycle.

What you'd actually do

  1. Collaborate and align with Sr. Medical Director/Director/Medical Advisor to develop the integrated evidence generation strategy for assigned therapeutic area(s), aligned with global/regional medical plans and corporate priorities.
  2. Lead the design development, execution, and oversight of observational studies, registries, pragmatic trials, external control arms, database studies, and patient-reported outcome research.
  3. Partner closely with HEOR, Market Access, Regulatory, Clinical Development, Pharmacovigilance, and Commercial Insights to ensure evidence addresses cross-functional needs.
  4. In collaboration with Sr. Medical Director/Director/Medical Advisor drive dissemination of RWE through publications, congress presentations, dossiers, and educational activities per overall therapeutic area congress strategy.
  5. Provide mentorship to junior RWE scientists and medical team members.

Skills

Required

  • Advanced degree in epidemiology, health economics, outcomes research, biostatistics, medicine, or related discipline (PhD, MD, PharmD, or MPH with strong RWE experience).
  • 8+ years’ experience in pharmaceutical/biotech industry, CRO, or academia with direct RWE/observational research leadership.
  • Demonstrated expertise in study design, epidemiologic/statistical methods, and working with RWD assets.
  • Strong understanding of payer/HTA requirements, regulatory frameworks, and GPP/GCP compliance.
  • Proven track record of peer-reviewed publications, congress presentations, and cross-functional leadership.
  • Excellent communication skills
  • ability to influence internal and external stakeholders at senior levels.
  • Experience managing vendors, RWE budgets, and complex project portfolios.

Nice to have

  • Champion innovation in data science, analytics platforms, and digital RWE solutions.
  • Contribute to enterprise-wide RWE governance, standards, and capability building.

What the JD emphasized

  • robust, high-quality evidence
  • critical data gaps
  • scientific leader
  • trusted partner
  • evidence generation strategy
  • evidence gaps
  • evidence plans
  • study design
  • study execution
  • real-world data (RWD) assets
  • cross-functional needs
  • dissemination of RWE
  • scientific integrity
  • compliance (GPP, GCP, SOPs)
  • transparency
  • RWE insights
  • Team & Capability Development
  • innovation in data science
  • analytics platforms
  • digital RWE solutions
  • enterprise-wide RWE governance
  • standards
  • capability building
  • Advanced degree in epidemiology, health economics, outcomes research, biostatistics, medicine, or related discipline (PhD, MD, PharmD, or MPH with strong RWE experience).
  • 8+ years’ experience in pharmaceutical/biotech industry, CRO, or academia with direct RWE/observational research leadership.
  • Demonstrated expertise in study design, epidemiologic/statistical methods, and working with RWD assets.
  • Strong understanding of payer/HTA requirements, regulatory frameworks, and GPP/GCP compliance.
  • Proven track record of peer-reviewed publications, congress presentations, and cross-functional leadership.
  • Excellent communication skills
  • ability to influence internal and external stakeholders at senior levels.
  • Experience managing vendors, RWE budgets, and complex project portfolios.